In a 60-year-old man who has not belched for 25 years and now experiences socially disabling flatulence, what is the etiology and what treatments are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Etiology: Aerophagia with Inability to Belch

This patient most likely has aerophagia combined with an inability to belch due to ineffective upper esophageal sphincter (UES) relaxation, causing swallowed air to accumulate in the intestines and colon, resulting in socially disabling flatulence. 1

Understanding the Mechanism

In aerophagia, excessive air swallowing leads to increased intragastric and intestinal gas. Critically, the swallowed air moves distally to the intestines and colon rather than being expelled orally through belching, making flatulence the predominant symptom rather than belching 1. The 25-year inability to belch suggests a chronic dysfunction where gastroesophageal gas reflux episodes fail to trigger UES relaxation, trapping air in the esophagus and allowing it to progress into the intestinal tract 2.

Key Pathophysiologic Features:

  • Air enters the esophagus through swallowing with UES opening
  • Air clears the esophagus via peristalsis, entering the stomach through lower esophageal sphincter relaxation
  • Unlike normal belching, the UES fails to relax in response to gastroesophageal gas reflux, preventing oral expulsion 2
  • Trapped air accumulates distally, causing bloating and excessive flatulence

Diagnostic Approach

High-resolution esophageal manometry with impedance monitoring is the definitive diagnostic test to confirm aerophagia and document the inability to belch 1. This testing will show:

  • Air influx into the esophagus with swallowing
  • Normal UES relaxation during deglutition
  • Absent UES relaxation during gastroesophageal gas reflux episodes 2
  • Intestinal gas accumulation on abdominal X-rays 1

Ambulatory 24-hour pH-impedance monitoring can quantify esophageal air presence time and document the extent of air entrapment 2.

Treatment Strategy

Primary Treatment: UES Botulinum Toxin Injection

Botulinum toxin injection into the UES is the most effective treatment for inability to belch, with evidence showing restoration of belching capacity in all treated patients 2. This intervention:

  • Reduces UES basal pressure significantly
  • Restores the ability to belch
  • Decreases esophageal air presence time from median 10.5% to 0.7%
  • Improves symptoms dramatically (VAS scores from 6.0 to 1.0) 2

Adjunctive Behavioral Therapies

Brain-gut behavioral therapies should be implemented alongside or following UES treatment 1:

  • Diaphragmatic breathing exercises to reduce air swallowing
  • Cognitive behavioral therapy (CBT) to address any anxiety-related air swallowing patterns
  • Speech therapy to modify swallowing patterns

Important Caveats:

  • Psychoeducation about the condition is essential—explain that this is a physiologic disorder with effective treatment 1
  • The condition stops during sleep and distraction, suggesting behavioral modulation plays a role 1
  • Dietary modifications (low FODMAP, carbohydrate restriction) may help reduce gas production but won't address the primary UES dysfunction 1

What NOT to Do:

  • Avoid empiric PPI therapy—this is not GERD-related 1
  • Don't order gastric emptying studies unless nausea/vomiting are present 1
  • Probiotics are not effective for this condition 1

Quality of Life Impact

This condition significantly impairs quality of life through social embarrassment and work productivity loss 1, 3. Prompt diagnosis and treatment with UES botulinum toxin can dramatically improve outcomes, with all patients in the key study showing symptom improvement within 3 months 2.

Related Questions

What are the causes, diagnostic approach, and treatment options for frequent burping (eructation) in adults?
What are the possible diagnoses for a 52-year-old man with intermittent bloating unrelated to meals, one month of excessive belching, and four days of incomplete stool evacuation, who has a soft non‑tender abdomen and no weight loss or loss of appetite?
In a 43-year-old man with foul-smelling flatulence and intermittent abdominal pain, what is the most likely diagnosis and recommended treatment?
In a 49-year-old man with persistent foul-smelling flatulence, intermittent abdominal pain, normal laboratory tests, normal abdominal ultrasound, normal vital signs, and a soft non-tender abdomen, what is the likely diagnosis and recommended treatment?
In a 49-year-old man with a one-year history of excessive foul-smelling flatulence, abdominal bloating, unintended weight loss, normal vital signs, and a normal abdominal ultrasound, what is the appropriate diagnostic workup and treatment plan?
What is the appropriate methocarbamol dosage to prescribe for an 81-year-old patient with back pain?
For a 65‑year‑old woman with a history of triple‑negative breast cancer, bilateral mastectomy, hysterectomy, presenting with anhedonia, low libido, vaginal dryness, and currently taking escitalopram (Lexapro), which systemic estrogen preparation (transdermal patch versus topical cream) is appropriate, and why is gabapentin preferred over progesterone for treating hot flashes and sleep disturbance?
A patient who combined tadalafil (Cialis) and sildenafil (Viagra) 28 days ago now has persistent penile firmness, discoloration, and difficulty maintaining erections with variable size—could this be a vein clot or phlebitis, and what is the appropriate management?
Should I use Motrin (ibuprofen) and apply hydrocortisone cream for persistent penile firmness, discoloration, and variable size after combining tadalafil and sildenafil?
In a colon cancer patient with loss of MLH1 and PMS2 protein expression and a somatic BRAF V600E mutation, could this represent Lynch syndrome?
What are the contraindications to using bupropion, aside from bulimia nervosa and a history of seizure disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.